Company · CIK 1191070
Neuphoria Therapeutics Inc.
| CIK | 1191070 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | C3 |
| Business address | MA |
| Listed | NEUP (Nasdaq) |
| First annual or quarterly report | 2022-10-14 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-283306 | 2024-11-18 | 2025-11-14 | 9 | |
| 333-284512 | 2025-01-24 | 2025-01-29 | 2 | |
| 333-271696 | 2023-05-05 | 2024-12-27 | 3 | |
| 333-280288 | 2024-06-18 | 2024-12-27 | 3 | |
| 333-268314 | 2022-11-10 | 2022-11-18 | 4 | |
| 333-261280 | 2021-11-22 | 2021-12-17 | 5 |
Filings
29| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-11-14 | 424B5Shelf takedown | 333-283306 | 0001213900-25-110865 |
| 2025-10-27 | 424B5Shelf takedown | 333-283306 | 0001213900-25-102387 |
| 2025-10-20 | 424B5Shelf takedown | 333-283306 | 0001213900-25-100387 |
| 2025-09-23 | 424B5Shelf takedown | 333-283306 | 0001213900-25-090330 |
| 2025-07-29 | 424B5Shelf takedown | 333-283306 | 0001213900-25-068691 |
| 2025-02-12 | 424B5Shelf takedown | 333-283306 | 0001213900-25-012481 |
| 2025-02-04 | 424B5Shelf takedown | 333-283306 | 0001213900-25-009546 |
| 2025-01-29 | EFFECTDeclared effective | 333-284512 | 9999999995-25-000236 |
| 2025-01-24 | S-3Shelf registered | 333-284512 | 0001213900-25-006517 |
| 2025-01-08 | EFFECTDeclared effective | 333-283306 | 9999999995-25-000061 |
| 2024-12-27 | EFFECTDeclared effective | 333-280288 | 9999999995-24-003928 |
| 2024-12-27 | EFFECTDeclared effective | 333-271696 | 9999999995-24-003926 |
| 2024-11-18 | S-3Shelf registered | 333-283306 | 0001213900-24-099678 |
| 2024-06-26 | EFFECTDeclared effective | 333-280288 | 9999999995-24-001976 |
| 2024-06-18 | F-1Registration filed | 333-280288 | 0001213900-24-053517 |
| 2023-05-17 | EFFECTDeclared effective | 333-271696 | 9999999995-23-001462 |
| 2023-05-05 | F-3Shelf registered | 333-271696 | 0001193125-23-137169 |
| 2022-11-18 | 424B4Final prospectus | 333-268314 | 0001193125-22-288543 |
| 2022-11-16 | EFFECTDeclared effective | 333-268314 | 9999999995-22-003319 |
| 2022-11-14 | F-1/AAmendment | 333-268314 | 0001193125-22-283501 |
| 2022-11-10 | F-1Registration filed | 333-268314 | 0001193125-22-282795 |
| 2022-10-31 | DRSDraft made public | 377-06435 | 0000950123-22-010597 |
| 2021-12-17 | 424B4Final prospectus | 333-261280 | 0001193125-21-361058 |
| 2021-12-15 | EFFECTDeclared effective | 333-261582 | 9999999995-21-004714 |
| 2021-12-15 | EFFECTDeclared effective | 333-261280 | 9999999995-21-004707 |
| 2021-12-13 | F-1/AAmendment | 333-261280 | 0001193125-21-354598 |
| 2021-12-08 | F-1/AAmendment | 333-261280 | 0001193125-21-351579 |
| 2021-11-22 | F-1Registration filed | 333-261280 | 0001193125-21-337012 |
| 2021-09-10 | DRSDraft made public | 377-05482 | 0000950123-21-012260 |